We are advancing antibiotic research by developing novel antibiotics and enhancing existing ones to overcome drug resistance. Our work targets bacterial defense systems and explores new drug formulations to improve treatment outcomes for resistant infections.
AI-Powered Drug Discovery and Global Collaborations
We utilize AI-driven screening and computational modeling to accelerate the discovery of both AMP-based and antibiotic therapies. Strategic partnerships with
March 25, 2025